{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:08:57Z","timestamp":1779084537657,"version":"3.51.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,4,11]],"date-time":"2012-04-11T00:00:00Z","timestamp":1334102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,4,11]],"date-time":"2012-04-11T00:00:00Z","timestamp":1334102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2012,6,1]]},"DOI":"10.1002\/emmm.201200232","type":"journal-article","created":{"date-parts":[[2012,4,11]],"date-time":"2012-04-11T12:04:50Z","timestamp":1334145890000},"page":"451-452","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Selecting for predisposition to cancer cachexia"],"prefix":"10.1038","volume":"4","author":[{"given":"Ioannis","family":"Gioulbasanis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis J.","family":"Vlachostergios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos N.","family":"Papandreou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,11]]},"reference":[{"key":"BFEMMM201200232_CR1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drudis.2007.10.008","volume":"13","author":"JM Argil\u00e9s","year":"2008","unstructured":"Argil\u00e9s JM, L\u00f3pez\u2010Soriano FJ, Busquets S (2008) Novel approaches to the treatment of cachexia. Drug Discov Today 13: 73\u201078","journal-title":"Drug Discov Today"},{"key":"BFEMMM201200232_CR2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00005-006-0010-6","volume":"54","author":"M Chen","year":"2006","unstructured":"Chen M, Geng JG (2006) P\u2010selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis. Arch Immunol Ther Exp (Warsz) 54: 75\u201084","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"BFEMMM201200232_CR3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","volume":"69","author":"WD Dewys","year":"1980","unstructured":"Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO, Jr, Engstrom PF, Ezdinli EZ, et al (1980) Prognostic effect of weight loss prior to chemotherapy 386 in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69: 491\u2010497","journal-title":"Am J Med"},{"key":"BFEMMM201200232_CR4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, et al (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12: 489\u2010495","journal-title":"Lancet Oncol"},{"key":"BFEMMM201200232_CR5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1517\/13543781003724690","volume":"19","author":"T Kung","year":"2010","unstructured":"Kung T, Springer J, Doehner W, Anker SD, von Haehling S (2010) Novel treatment approaches to cachexia and sarcopenia: highlights from the 5th Cachexia Conference. Expert Opin Investig Drugs 19: 579\u2010585","journal-title":"Expert Opin Investig Drugs"},{"key":"BFEMMM201200232_CR6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13539-010-0007-1","volume":"1","author":"K Lenk","year":"2010","unstructured":"Lenk K, Schuler G, Adams V (2010) Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J Cachexia Sarcopenia Muscle 1: 9\u201021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"BFEMMM201200232_CR7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejca.2005.07.026","volume":"42","author":"M Muscaritoli","year":"2006","unstructured":"Muscaritoli M, Bossola M, Aversa Z, Bellantone R, Rossi Fanelli F (2006) Prevention and treatment of cancer cachexia: new insights into and old problem. Eur J Cancer 42: 31\u201041","journal-title":"Eur J Cancer"},{"key":"BFEMMM201200232_CR8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13539-011-0028-4","volume":"2","author":"F Penna","year":"2011","unstructured":"Penna F, Busquets S, Pin F, Toledo M, Baccino FM, L\u00f3pez\u2010Soriano FJ, Costelli P, Argil\u00e9s JM (2011) Combined approach to counteract experimental cancer cachexia: eicosapentaenoic acid and training exercise. J Cachexia Sarcopenia Muscle 2: 95\u2010104","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"BFEMMM201200232_CR9","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","volume":"15","author":"CM Prado","year":"2009","unstructured":"Prado CM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, Tonkin K, Mackey JR, Koski S, Pituskin E, Sawyer MB (2009) Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 15: 2920\u20102926","journal-title":"Clin Cancer Res"},{"key":"BFEMMM201200232_CR10","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1158\/1078-0432.CCR-09-1525","volume":"15","author":"BH Tan","year":"2009","unstructured":"Tan BH, Birdsell LA, Martin L, Baracos VE, Fearon KC (2009) Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 15: 6973\u20106979","journal-title":"Clin Cancer Res"},{"key":"BFEMMM201200232_CR11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/SPC.0b013e32833e4a5d","volume":"4","author":"BH Tan","year":"2010","unstructured":"Tan BH, Fearon KC (2010) Cytokine gene polymorphisms and susceptibility to cachexia. Curr Opin Support Palliat Care 4: 243\u2010248","journal-title":"Curr Opin Support Palliat Care"},{"key":"BFEMMM201200232_CR12","doi-asserted-by":"publisher","unstructured":"Tan BH, Flanvad T, Braun TH, Vigano A, Strasser F, Deans CD, Skipworth RJ, Solheim TS, Damaraju S, Ross JA, et al (2012) P\u2010selectin genotype is associated with the development of cancer cachexia. EMBO Mol Med DOI: https:\/\/doi.org\/10.1002\/emmm.201200231","DOI":"10.1002\/emmm.201200231"},{"key":"BFEMMM201200232_CR13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/physrev.00016.2008","volume":"89","author":"MJ Tisdale","year":"2009","unstructured":"Tisdale MJ (2009) Mechanisms of cancer cachexia. Physiol Rev 89: 381\u2010410","journal-title":"Physiol Rev"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1002\/emmm.201200232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/emmm.201200232","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1002\/emmm.201200232\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.1002\/emmm.201200232","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1002\/emmm.201200232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:02:05Z","timestamp":1779084125000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1002\/emmm.201200232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,11]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6,1]]}},"alternative-id":["BFEMMM201200232"],"URL":"https:\/\/doi.org\/10.1002\/emmm.201200232","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,11]]},"assertion":[{"value":"11 April 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}